QSAM Biosciences
Financial ratios & Valuation

Historical Multiples (2013 – 2023)

2013 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.09K-0.06-0.82-1.71-3.10-0.21-0.52-0.44-1.23-0.00-0.76-3.10
Price/Sales ratio
138.59K11.4630.9962.4137.010.53N/AN/AN/AN/AN/A0.53
Price/Book Value ratio
-3.28K-0.09-0.73-1.43-0.37-0.12-0.6520.58-6.160.01-3.63-0.12
Price/Cash Flow ratio
-5.66K-0.12-2.39-3.86-1.15-0.49-3.79-3.22-2.76-0.00-1.84-0.49
Price/Free Cash Flow ratio
-5.66K-0.11-2.38-3.86-1.15-0.49-3.79-3.22-2.76-0.00-1.84-0.49
Price/Earnings Growth ratio
N/A0.000.01-0.160.03-0.000.040.000.01N/A-0.01-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
71.28%70.99%82.07%15.33%100%99.96%N/AN/AN/AN/AN/A99.96%
Operating Profit Margin
-1886.97%-16923.99%-5118.27%-1772.51%-4733.21%-126.75%N/AN/AN/AN/AN/A-4733.21%
Pretax Profit Margin
-6606.81%-17680.10%-3744.30%-3635.95%-1191.78%-74.39%N/AN/AN/AN/AN/A-1191.78%
Net Profit Margin
-6606.81%-17680.10%-3744.30%-3635.95%-1191.78%-250.49%N/AN/AN/AN/AN/A-1191.78%
Effective Tax Rate
-71.43%-3.71%51.83%7.60%-12.58%-236.69%8.02%-6.58%-10.82%0.08%-7.45%-12.58%
Return on Assets
-865.74%-1478.88%-1700.29%-891.04%-247.68%-28197.94%-25250.40%-764.47%-1666.08%-257.62%-2520.59%-28197.94%
Return On Equity
156.65%138.91%88.59%83.60%12.19%60.03%125.14%-4609.96%499.82%-653.40%516.79%12.19%
Return on Capital Employed
55.73%152.04%121.09%-7124.67%528.60%30.64%31.77%-3987.22%449.32%-586.37%698.90%528.60%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.23N/A
Quick Ratio
0.010.010.001.060.340.000.001.190.231.650.140.00
Cash ratio
0.010.000.001.040.340.000.001.070.141.340.140.00
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
31.50K34.08K40.63K642.36N/A248.43K0.00N/AN/AN/AN/A248.43K
Cash Conversion Cycle
-31.50K-34.08K-40.63K-642.36N/A-248.43KN/AN/AN/AN/AN/A-248.43K
Debt Ratios
Debt Ratio
1.081.825.1811.2619.48420.79163.070.341.230.004.33420.79
Debt Equity Ratio
-0.19-0.17-0.27-1.05-0.95-0.89-0.802.07-0.370.01-0.81-0.95
Long-term Debt to Capitalization
-0.24N/AN/A175.81-9.91-0.00-0.020.65N/AN/AN/A-9.91
Total Debt to Capitalization
-0.24-0.20-0.3718.70-23.41-8.60-4.210.67-0.590.01N/A-23.41
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-230.32N/A
Cash Flow to Debt Ratio
-2.94-4.28-1.13-0.35-0.34-0.28-0.21-3.07-6.01-379.75N/A-0.34
Company Equity Multiplier
-0.18-0.09-0.05-0.09-0.04-0.00-0.006.03-0.292.53-0.18-0.00
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-24.46-93.44-12.92-16.14-32.05-1.06N/AN/AN/AN/AN/A-32.05
Free Cash Flow / Operating Cash Flow Ratio
11.041.00111111111
Cash Flow Coverage Ratio
-2.94-4.28-1.13-0.35-0.34-0.28-0.21-3.07-6.01-379.75N/A-0.34
Short Term Coverage Ratio
N/A-4.28-1.13-7.31-6.47-0.28-0.22-41.61-6.01-379.75-8.46-0.28
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A